Matthew Judson is a research associate in the UNC Neuroscience Center at the University of North Carolina at Chapel Hill.
Matthew Judson
Research associate
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
Explore more from The Transmitter
What makes computation possible in brains?
Nima Dehghani formalizes how computation can arise out of physical systems, such as brains, and describes the “special sauce” for real biological agency.
What makes computation possible in brains?
Nima Dehghani formalizes how computation can arise out of physical systems, such as brains, and describes the “special sauce” for real biological agency.
Fish brains follow swimming friends to avoid foes
A subset of neurons in glassfish activate when the animals see others escape, new research shows, offering clues for how collective behaviors emerge from individual neural activity.
Fish brains follow swimming friends to avoid foes
A subset of neurons in glassfish activate when the animals see others escape, new research shows, offering clues for how collective behaviors emerge from individual neural activity.
Scaling up n-of-1 trials; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 November.
Scaling up n-of-1 trials; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 November.